Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03348722Completed

Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START

Role: lead

NCT04372992Not ApplicableTerminated

The Stoma Closure Before or After Adjuvant Therapy Trial

Role: collaborator

NCT00916708Not ApplicableUnknown

Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients

Role: collaborator

All 3 trials loaded